Credent Connect N Care Limited
SMECREDENT • BSE, NSE
Issue details
Price band
₹179 - ₹189
Lot size
600 shares
Issue size
₹67.36 Cr
Min. investment
₹1,13,400
Registrar
KFin Technologies
Grey market premium
Est. gain+₹92 · 49%
Save your family's PANs once and check allotment for everyone the moment results are out.
Sign in with a mobile OTP. It takes 20 seconds.
IPO Timeline
Open
13 Aug
Close
17 Aug
Allotment
18 Aug
Listing
20 Aug
- Refunds & demat credit
- 19 Aug 2026
- Mandate end
- 1 Sep 2026
We calculate these dates from the allotment and close dates, so please treat them as indicative.
Application size
| Category | Minimum | Maximum |
|---|---|---|
| Retail | 600shares 1 lot · ₹1,13,400 | 600shares 1 lot · ₹1,13,400 |
| HNI | 1,200shares 2 lots · ₹2,26,800 | No limit funds permitting |
Based on the upper price band of ₹189 and a lot of 600 shares.
Subscription
| Quota | Shares offered | Shares bid | Applications | Subscribed |
|---|---|---|---|---|
| Total | — | 50,74,35,000 | 2,30,223 | — |
Last updated 69 days ago.
Issue structure
Face value
₹10 per share
Issue type
Bookbuilding IPO
Sale type
Fresh capital only
Fresh issue
₹89 Cr
47,16,000 shares
Shares pre-issue
1,32,54,900
Shares post-issue
1,82,22,900
Valuation & ratios
| Metric | Pre-IPO | Post-IPO |
|---|---|---|
| EPS | 13.92 | 10.12 |
| P/E | 13.58 | 18.68 |
| Market cap | ₹250.52 Cr. | ₹687.09 Cr |
| KPI | Mar 31, 2026 | Mar 31, 2025 |
|---|---|---|
| ROE | 61.81% | 15.20% |
| ROCE | 40.00% | 16.96% |
| Debt/Equity | 0.50 | 0.47 |
| RoNW | 42.13% | 14.13% |
| PAT Margin | 8.61% | 2.88% |
| EBITDA Margin | 13.29% | 6.41% |
| NAV | 33.12 | 15.59 |
| Price to Book Value | 5.71 | 12.12 |
Financials
| Metric | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|
| Total income | 78.23 | 76.02 |
| Profit after tax | 2.25 | 2.66 |
| EBITDA | 4.99 | 4.3 |
| Net worth | 15.9 | 13.66 |
| Assets | 29.5 | 26.41 |
| Reserves & surplus | 15.7 | 13.46 |
| Total borrowing | 7.42 | 6.85 |
Figures in ₹ crore, as reported by the company in its offer document.
Objects of the issue
- 1.Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to meet its working capital requirement₹26.8 Cr
- 2.Investment in the wholly owned subsidiary, Credent Healthcare Private Limited to finance its capital expenditure requirements for machinery₹3 Cr
- 3.To meet Working Capital Requirements₹37 Cr
- 4.Repayment and/or repayment, in full or part, of borrowing availed by the Company₹6 Cr
- 5.General corporate purposes₹8.92 Cr
- 6.Issue Expenses₹12.17 Cr
What the company says it intends to do with the money raised.
Recent comparable IPOs
| Company | Issue price | P/E | Listing close | Listing gain |
|---|---|---|---|---|
| Pramodini Medicare Ltd.SME | ₹118 | 11.34 | ₹121.65 | +3.09% |
| Modern Diagnostic & Research Centre Ltd.SME | ₹90 | 11.04 | ₹94.99 | +5.54% |
| Invicta Diagnostic Ltd.SME | ₹85 | 14.51 | ₹96.70 | +13.76% |
| Gaudium IVF & Women Health Ltd.Mainboard | ₹79 | 25.36 | ₹80.26 | +1.59% |
| Nephrocare Health Services Ltd.Mainboard | ₹460 | 63.52 | ₹471.25 | +2.45% |
Past listing performance of comparable issues. This is not a forecast: listing gains vary widely and can turn negative.
Issue fundamentals compiled from the company's offer document via Chittorgarh, last read 27 Sep 2026. Always verify against the RHP before applying.